Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
NPCE · against 378 other Healthcare companies of similar size
Ranked #57 of 379 · scores higher than 85% of peers
Bars: peers in each 10-point band of the growth score27 peers with a growth score of 80–89, including NPCE · Click a bar to see the companies
Mainly thanks to its revenue growth and 3-year revenue growth, which are stronger than most Healthcare peers.
| Metric | NPCE | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 393 reported | 33.2% | 2.7% | 88% | 33% | |
| Earnings per share growthHigher is better · 189 reported | Not reported | 1.4% | — | — | 33% |
| 3-year revenue growthHigher is better · 372 reported | 24.9% | 3.0% | 86% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 2 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 609M USD | 99 | 91 | |
| 55 | 555M EUR (≈$611M) | 83 | 25 | |
| 55 | 267M USD | 83 | 75 | |
| 57 | 578M USD | 81 | 73 | |
| 57 | 650M USD | 81 | 48 | |
| 57 | 423M USD | 81 | 29 | |
| 60 | 5.9B HKD (≈$760M) | 80 | 59 | |
| 61 | 6.6B HKD (≈$840M) | 79 | 71 | |
| 61 | 449M USD | 79 | 72 | |
| 61 | 3.9B SEK (≈$385M) | 79 | 23 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score